CORONAVIRUSCOVID WORLDWORLD

European Regulator Could OK 1st COVID-19 Vaccine On Dec. 29

0
FILE - This May 4, 2020, file photo provided by the University of Maryland School of Medicine, shows the first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore. The German pharmaceutical company BioNTech and its U.S. partner Pfizer say they have submitted an application for conditional approval of their coronavirus vaccine with the European Medicines Agency. (Courtesy of University of Maryland School of Medicine via AP, File)

(AP) — European regulators say they may approve a coronavirus vaccine developed by drugmakers Pfizer and BioNTech within four weeks. That time frame, while sped up, could mean the shot is rolled out first in the United States and Britain. The European Medicines Agency said Tuesday it plans to convene a meeting by Dec. 29 to decide if there is enough safety and efficacy data about the vaccine for it to be approved, the regulator said. The agency also said it could decide as early as Jan. 12 whether to approve a rival vaccine developed by Moderna Inc. The German pharmaceutical company BioNTech and its U.S. partner Pfizer have said that clinical trials showed their vaccine is 95% effective.

Olympic Rings Back In Tokyo Bay; A Sign Of Hope In Pandemic

Previous article

UnitedHealth Forecast For 2021 Is Dinged By The Coronavirus

Next article

You may also like

More in CORONAVIRUS